High-Dose Inhaled Nitric Oxide for the Treatment of Spontaneously Breathing Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19) Pneumonia
Carlo Valsecchi, Shahzad Shaefi(Beth Israel Deaconess Medical Center), Ai‐ris Y. Collier(Beth Israel Deaconess Medical Center), Dario Winterton(Harvard University), Elizabeth Hohmann(Harvard University), Shivali Mukerji, Bijan Safaee Fakhr(University of Alabama at Birmingham Hospital), Riccardo Pinciroli, Jeanne B. Ackman(MGH Institute of Health Professions), Lauren E. Gibson, Carolyn La Vita, Fumito Ichinose(Harvard University), Jamel Ortoleva(Boston Medical Center), Pankaj Arora(University of Oxford), Lorenzo Berra(Massachusetts General Hospital), Ala Nozari(Harvard University), Anjali J. Kaimal, William H. Barth, Ryan W. Carroll(Northwestern University)
Cited by 26
Related Papers
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Nontyphoidal Salmonellosis
|Clinical Infectious Diseases|2001|995
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Inhaled Nitric Oxide
|Circulation|2004|533